Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Biopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The biopharmaceutical company announced a strategic restructuring plan, laying off about 500 ...

According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 13.20%, which means the company has less short interest than most of its peers. Did you ...

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 10% after the clinical-stage biopharmaceutical company announced the publication of promising preclinical data from its ...

Sarepta's cost-saving moves, FDA surprises, and pipeline potential position SRPT as a unique opportunity. Read here for an ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Tony tucks into some fresh biotech stocks on that he will be keenly watching after a sector down period has left some bargains on the menu.

Alphabet (Google) is investing in biotech penny stocks. Should you? Explore Alphabet's investment strategy and discover potential penny stocks to consider.

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

On the first point, we talk a lot around here about small public companies that get gobbled up by crypto entrepreneurs so ...